Protein misfolding and aggregation in cataract disease and prospects for prevention

Trends in Molecular Medicine

Volumn 18, Issue 5, 2012, Pages 273-282

  Moreau, Kate L ^a   King, Jonathan A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AGENTS ACTING ON THE EYE; ALDOSE REDUCTASE INHIBITOR; CALPASTATIN; CRYSTALLIN; DODECYL SULFATE SODIUM; FLAVONOID; GARLIC EXTRACT; HERBACEOUS AGENT; PANTETHINE; REACTIVE OXYGEN METABOLITE; SORBITOL;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BROCCOLI; CATARACT; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL TRIAL (TOPIC); CONGENITAL CATARACT; DAUGHTER CELL; DIABETES MELLITUS; DISEASE COURSE; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; LENS; LIGHT SCATTERING; LIPID PEROXIDATION; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RIBOSOME; SENILE CATARACT; SHRUB; SICKLE CELL ANEMIA; UNITED STATES; VITEX NEGUNDO;

ANIMALS; CATARACT; CRYSTALLINS; HUMANS; LENS, CRYSTALLINE; PROTEIN FOLDING;

EID: 84860513605     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.03.005     Document Type: Review

References (116)

1. Augusteyn R.C. On the growth and internal structure of the human lens. Exp. Eye Res. 2010, 90:643-654.
2. Michael R., et al. Changes in the refractive index of lens fibre membranes during maturation - impact on lens transparency. Exp. Eye Res. 2003, 77:93-99.
3. Bassnett S. Lens organelle degradation. Exp. Eye Res. 2002, 74:1-6.
4. Delaye M., Tardieu A. Short-range order of crystallin proteins accounts for eye lens transparency. Nature 1983, 302:415-417.
5. The Human Eye: Structure and Function 1999, Sinauer Associates, Inc. C.W. Oyster (Ed.).
6. Basak A., et al. High-resolution X-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract. J. Mol. Biol. 2003, 328:1137-1147.
7. Purkiss A.G., et al. The X-ray crystal structure of human gamma S-crystallin C-terminal domain. J. Biol. Chem. 2002, 277:4199-4205.
8. Van Montfort R.L., et al. Crystal structure of truncated human betaB1-crystallin. Protein Sci. 2003, 12:2606-2612.
9. Bagneris C., et al. Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20. J. Mol. Biol. 2009, 392:1242-1252.
10. Laganowsky A., et al. Crystal structures of truncated alphaA and alphaB crystallins reveal structural mechanisms of polydispersity important for eye lens function. Protein Sci. 2010, 19:1031-1043.
11. Congdon N., et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch. Ophthalmol. 2004, 122:487-494.
12. Prevent Blindness America N.E.I. Vision Problems in the U.S.: Prevalence of Adult Vision Impairment and Age-related Eye Disease in America 2008, Published in conjunction with the National Eye Institute, pp. 22-25. update to the 4th edn.
13. Ashwin P.T., et al. Advances in cataract surgery. Clin. Exp. Optom. 2009, 92:333-342.
14. Brian G., Taylor H. Cataract blindness - challenges for the 21st century. Bull. World Health Organ. 2001, 79:249-256.
15. Murthy G.V., et al. Prevalence of lens opacities in North India: the INDEYE feasibility study. Invest. Ophthalmol. Vis. Sci. 2007, 48:88-95.
16. Nirmalan P.K., et al. Lens opacities in a rural population of southern India: the Aravind Comprehensive Eye Study. Invest. Ophthalmol. Vis. Sci. 2003, 44:4639-4643.
17. Hains P.G., Truscott R.J. Post-translational modifications in the nuclear region of young, aged, and cataract human lenses. J. Proteome Res. 2007, 6:3935-3943.
18. Hains P.G., Truscott R.J. Proteomic analysis of the oxidation of cysteine residues in human age-related nuclear cataract lenses. Biochim. Biophys. Acta 2008, 1784:1959-1964.
19. Lampi K.J., et al. Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp. Eye Res. 1998, 67:31-43.
20. Ma Z., et al. Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp. Eye Res. 1998, 67:21-30.
21. Zhang Z., et al. Human beta-crystallins modified by backbone cleavage, deamidation and oxidation are prone to associate. Exp. Eye Res. 2003, 77:259-272.
22. Wilmarth P.A., et al. Age-related changes in human crystallins determined from comparative analysis of post-translational modifications in young and aged lens: does deamidation contribute to crystallin insolubility?. J. Proteome Res. 2006, 5:2554-2566.
23. Hains P.G., Truscott R.J. Age-dependent deamidation of lifelong proteins in the human lens. Invest. Ophthalmol. Vis. Sci. 2010, 51:3107-3114.
24. Truscott R.J. Age-related nuclear cataract-oxidation is the key. Exp. Eye Res. 2005, 80:709-725.
25. Hanson S.R., et al. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp. Eye Res. 2000, 71:195-207.
26. Kim Y.H., et al. Deamidation, but not truncation, decreases the urea stability of a lens structural protein, betaB1-crystallin. Biochemistry 2002, 41:14076-14084.
27. Lampi K.J., et al. Deamidation in human lens betaB2-crystallin destabilizes the dimer. Biochemistry 2006, 45:3146-3153.
28. Takata T., et al. Deamidation destabilizes and triggers aggregation of a lens protein, betaA3-crystallin. Protein Sci. 2008, 17:1565-1575.
29. Flaugh S.L., et al. Glutamine deamidation destabilizes human gammaD-crystallin and lowers the kinetic barrier to unfolding. J. Biol. Chem. 2006, 281:30782-30793.
30. Udupa E.G., Sharma K.K. Effect of oxidized betaB3-crystallin peptide on lens betaL-crystallin: interaction with betaB2-crystallin. Invest. Ophthalmol. Vis. Sci. 2005, 46:2514-2521.
31. Udupa P.E., Sharma K.K. Effect of oxidized betaB3-crystallin peptide (152-166) on thermal aggregation of bovine lens gamma-crystallins: identification of peptide interacting sites. Exp. Eye Res. 2005, 80:185-196.
32. Santhoshkumar P., et al. αA-Crystallin peptide SDRDKFVIFLDVKHF accumulating in aging lens impairs the function of alpha-crystallin and induces lens protein aggregation. PloS ONE 2011, 6:e19291.
33. Santhoshkumar P., et al. Significance of interactions of low molecular weight crystallin fragments in lens aging and cataract formation. J. Biol. Chem. 2008, 283:8477-8485.
34. Bloemendal H., et al. Ageing and vision: structure, stability and function of lens crystallins. Prog. Biophys. Mol. Biol. 2004, 86:407-485.
35. Carver J.A., et al. Age-related changes in bovine alpha-crystallin and high-molecular-weight protein. Exp. Eye Res. 1996, 63:639-647.
36. Horwitz J. The function of alpha-crystallin. Invest. Ophthalmol. Vis. Sci. 1993, 34:10-22.
37. Heys K.R., et al. Presbyopia and heat: changes associated with aging of the human lens suggest a functional role for the small heat shock protein, alpha-crystallin, in maintaining lens flexibility. Aging Cell 2007, 6:807-815.
38. Benedek G.B. Cataract as a protein condensation disease: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 1997, 38:1911-1921.
39. Evans P., et al. The P23T cataract mutation causes loss of solubility of folded gammaD-crystallin. J. Mol. Biol. 2004, 343:435-444.
40. Kmoch S., et al. Link between a novel human gammaD-crystallin allele and a unique cataract phenotype explained by protein crystallography. Hum. Mol. Genet. 2000, 9:1779-1786.
41. Pande A., et al. Crystal cataracts: human genetic cataract caused by protein crystallization. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6116-6120.
42. Pande A., et al. Molecular basis of a progressive juvenile-onset hereditary cataract. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1993-1998.
43. Jaenicke R., Seckler R. Protein misassembly in vitro. Adv. Protein Chem. 1997, 50:1-59.
44. Moreno-Gonzalez I., Soto C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin. Cell Dev. Biol. 2011, 22:482-487.
45. Colon W., Kelly J.W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992, 31:8654-8660.
46. Lomas D.A., et al. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992, 357:605-607.
47. Bayro M.J., et al. High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure. Biochemistry 2010, 49:7474-7484.
48. Nelson R., Eisenberg D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 2006, 16:260-265.
49. Petty S.A., Decatur S.M. Intersheet rearrangement of polypeptides during nucleation of {beta}-sheet aggregates. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14272-14277.
50. Bennett M.J., et al. Deposition diseases and 3D domain swapping. Structure 2006, 14:811-824.
51. Metlapally S., et al. Analysis of nuclear fiber cell cytoplasmic texture in advanced cataractous lenses from Indian subjects using Debye-Bueche theory. Exp. Eye Res. 2008, 86:434-444.
52. Marsili S., et al. Cataract formation in a strain of rats selected for high oxidative stress. Exp. Eye Res. 2004, 79:595-612.
53. Kosinski-Collins M.S., King J. In vitro unfolding, refolding, and polymerization of human gammaD crystallin, a protein involved in cataract formation. Protein Sci. 2003, 12:480-490.
54. Acosta-Sampson L., King J. Partially folded aggregation intermediates of human gammaD-, gammaC-, and gammaS-crystallin are recognized and bound by human alphaB-crystallin chaperone. J. Mol. Biol. 2010, 401:134-152.
55. Wang S., et al. The benefits of being beta-crystallin heteromers: betaB1-crystallin protects betaA3-crystallin against aggregation during co-refolding. Biochemistry 2011, 50:10451-10461.
56. Takata T., et al. Deamidation alters interactions of beta-crystallins in hetero-oligomers. Mol. Vis. 2009, 15:241-249.
57. Das P., et al. Aggregation of gamma-crystallins associated with human cataracts via domain swapping at the C-terminal beta-strands. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10514-10519.
58. Papanikolopoulou K., et al. Formation of amyloid fibrils in vitro by human gammaD-crystallin and its isolated domains. Mol. Vis. 2008, 14:81-89.
59. Wang Y., et al. Formation of amyloid fibrils in vitro from partially unfolded intermediates of human C-crystallin. Invest. Ophthalmol. Vis. Sci. 2010, 51:672-678.
60. Moran S.D., et al. Two-dimensional IR spectroscopy and segmental 13C labeling reveals the domain structure of human gammaD-crystallin amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:3329-3334.
61. Meehan S., et al. Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J. Biol. Chem. 2004, 279:3413-3419.
62. Sandilands A., et al. Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J. 2002, 21:6005-6014.
63. Banerjee P.R., et al. Increased hydrophobicity and decreased backbone flexibility explain the lower solubility of a cataract-linked mutant of gammaD-crystallin. J. Mol. Biol. 2011, 412:647-659.
64. Jung J., et al. The structure of the cataract-causing P23T mutant of human gammaD-crystallin exhibits distinctive local conformational and dynamic changes. Biochemistry 2009, 48:2597-2609.
65. Kong F., King J. Contributions of aromatic pairs to the folding and stability of long-lived human gammaD-crystallin. Protein Sci. 2011, 20:513-528.
66. Talla V., et al. Visualization of in situ intracellular aggregation of two cataract-associated human gamma-crystallin mutants: lose a tail, lose transparency. Invest. Ophthalmol. Vis. Sci. 2008, 49:3483-3490.
67. Fu L., Liang J.J. Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest. Ophthalmol. Vis. Sci. 2003, 44:1155-1159.
68. Fu L., Liang J.J.N. Conformational change and destabilization of cataract gammaC-crystallin T5P mutant. FEBS Lett. 2002, 513:213-216.
69. Liu B.F., et al. Protein-protein interactions involving congenital cataract T5P gammaC-crystallin mutant: a confocal fluorescence microscopy study. Exp. Eye Res. 2008, 87:515-520.
70. Ma Z., et al. The G18V CRYGS mutation associated with human cataracts increases gammaS-crystallin sensitivity to thermal and chemical stress. Biochemistry 2009, 48:7334-7341.
71. Ma Z., et al. Overexpression of human gammaC-crystallin 5bp duplication disrupts lens morphology in transgenic mice. Invest. Ophthalmol. Vis. Sci. 2011, 52:5369-5375.
72. Wang K., et al. γD-Crystallin associated protein aggregation and lens fiber cell denucleation. Invest. Ophthalmol. Vis. Sci. 2007, 48:3719-3728.
73. Churchill A., Graw J. Clinical and experimental advances in congenital and paediatric cataracts. Philos. Trans. R. Soc. Lond. Ser. B: Biol. Sci. 2011, 366:1234-1249.
74. Lee S., et al. A single destabilizing mutation (F9S) promotes concerted unfolding of an entire globular domain in gammaS-crystallin. J. Mol. Biol. 2010, 399:320-330.
75. Sinha D., et al. A temperature-sensitive mutation of Crygs in the murine Opj cataract. J. Biol. Chem. 2001, 276:9308-9315.
76. Moreau K.L., King J. Hydrophobic core mutations associated with cataract development in mice destabilize human D-crystallin. J. Biol. Chem. 2009, 284:33285-33295.
77. Pollreisz A., Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J. Ophthalmol. 2010, 2010:608751.
78. Shiels A., Hejtmancik J.F. Genetic origins of cataract. Arch. Ophthalmol. 2007, 125:165-173.
79. Barbazetto I.A., et al. Oxygen tension in the rabbit lens and vitreous before and after vitrectomy. Exp. Eye Res. 2004, 78:917-924.
80. Kyselova Z. Different experimental approaches in modelling cataractogenesis: an overview of selenite-induced nuclear cataract in rats. Interdisciplinary Toxicol. 2010, 3:3-14.
81. Shearer T.R., et al. Selenite nuclear cataract: review of the model. Mol. Vis. 1997, 3:8.
82. Rooban B.N., et al. Vitex negundo attenuates calpain activation and cataractogenesis in selenite models. Exp. Eye Res. 2009, 88:575-582.
83. Sasikala V., et al. Moringa oleifera prevents selenite-induced cataractogenesis in rat pups. J. Ocul. Pharmacol. Ther. 2010, 26:441-447.
84. Delcourt C., et al. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liees a l'Age (POLA) study. Arch. Ophthalmol. 2000, 118:385-392.
85. McCarty C.A., Taylor H.R. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev. Ophthalmol. 2002, 35:21-31.
86. Wang Y., King J.A. Cataract as a protein-aggregation disease. Protein Misfolding Diseases: Current and Emerging Principles and Therapies 2010, 487-515. John Wiley & Sons, Inc. M. Ramirez-Alvarado (Ed.).
87. Giblin F.J., et al. UVA light in vivo reaches the nucleus of the guinea pig lens and produces deleterious, oxidative effects. Exp. Eye Res. 2002, 75:445-458.
88. Simpanya M.F., et al. Measurement of lens protein aggregation in vivo using dynamic light scattering in a guinea pig/UVA model for nuclear cataract. Photochem. Photobiol. 2008, 84:1589-1595.
89. Mizdrak J., et al. Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic. Biol. Med. 2008, 44:1108-1119.
90. Chen J., et al. Mechanism of the very efficient quenching of tryptophan fluorescence in human gammaD- and gammaS-crystallins: the gamma-crystallin fold may have evolved to protect tryptophan residues from ultraviolet photodamage. Biochemistry 2009, 48:3708-3716.
91. Chen J., et al. Mechanism of the highly efficient quenching of tryptophan fluorescence in human gammaD-crystallin. Biochemistry 2006, 45:11552-11563.
92. De Maria A., et al. Calpain expression and activity during lens fiber cell differentiation. J. Biol. Chem. 2009, 284:13542-13550.
93. Biswas S., et al. Calpains: targets of cataract prevention?. Trends Mol. Med. 2004, 10:78-84.
94. Li N., et al. Protective effects and mechanism of tetramethylpyrazine against lens opacification induced by sodium selenite in rats. Exp. Eye Res. 2011, 93:98-102.
95. Sharma K.K., Santhoshkumar P. Lens aging: effects of crystallins. Biochim. Biophys. Acta 2009, 1790:1095-1108.
96. Taylor H.R. Cataract: how much surgery do we have to do?. Br. J. Ophthalmol. 2000, 84:1-2.
97. Vibin M., et al. Broccoli regulates protein alterations and cataractogenesis in selenite models. Curr. Eye Res. 2010, 35:99-107.
98. Javadzadeh A., et al. Preventive effect of onion juice on selenite-induced experimental cataract. Indian J. Ophthalmol. 2009, 57:185-189.
99. Manikandan R., et al. Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups. Curr. Eye Res. 2010, 35:122-129.
100. Stefek M. Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdisciplinary Toxicol. 2011, 4:69-77.
101. Harding J.J. Can drugs or micronutrients prevent cataract?. Drugs Aging 2001, 18:473-486.
102. Babizhayev M.A., et al. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D 2002, 3:87-103.
103. Ha J.W., et al. Ability of N-acetylcarnosine to protect lens crystallins from oxidation and oxidative damage by radical probe mass spectrometry (RP-MS). Rapid Commun. Mass Spectrom. 2010, 24:2900-2908.
104. Varma S.D., et al. Inhibition of selenite-induced cataract by caffeine. Acta Ophthalmol. 2010, 88:e245-e249.
105. Varma S.D., et al. UV-B-induced damage to the lens in vitro: prevention by caffeine. J. Ocul. Pharmacol. Ther. 2008, 24:439-444.
106. Randazzo J., et al. Orally active multi-functional antioxidants delay cataract formation in streptozotocin (type 1) diabetic and gamma-irradiated rats. PLoS ONE 2011, 6:e18980.
107. Ferreira N., et al. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 2011, 585:2424-2430.
108. Meng F., et al. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 2010, 49:8127-8133.
109. Gong B., et al. Sodium 4-phenylbutyrate ameliorates the effects of cataract-causing mutant gammaD-crystallin in cultured cells. Mol. Vis. 2010, 16:997-1003.
110. Goulet D.R., et al. Inhibition of unfolding and aggregation of lens protein human gamma D crystallin by sodium citrate. Exp. Eye Res. 2011, 93:371-381.
111. Knee K.M., et al. The group II chaperonin Mm-Cpn binds and refolds human gammaD crystallin. Protein Sci. 2011, 20:30-41.
112. Mitchell P., et al. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology 1997, 104:581-588.
113. Lampi K.J., et al. Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens. J. Biol. Chem. 1997, 272:2268-2275.
114. Takata T., et al. Deamidation alters the structure and decreases the stability of human lens betaA3-crystallin. Biochemistry 2007, 46:8861-8871.
115. Peschek J., et al. The eye lens chaperone alpha-crystallin forms defined globular assemblies. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13272-13277.
116. Smith M.A., et al. Mutation of interfaces in domain-swapped human betaB2-crystallin. Protein Sci. 2007, 16:615-625.